#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cervix carcinoma Restless legs syndrome Adenocarcinoma gastric Piriformis syndrome Cushing's syndrome Henoch-Schonlein purpura nephritis Pancreatic carcinoma metastatic Retinitis pigmentosa Progressive supranuclear palsy Marginal zone lymphoma Inborn error of metabolism Bulbospinal muscular atrophy congenital Neurodegenerative disorder Antithrombin III deficiency Hyperadrenocorticism More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Trials in Disease Hypereosinophilic syndrome Rhabdomyosarcoma Fabry’s disease – Trials in Disease Chondrosarcoma Sarcoidosis – Basic Information KBG syndrome – Life with Disease Wolfram syndrome – Life with Disease Progressive multifocal leukoencephalopathy – Diagnostics Nodal marginal zone B-cell lymphoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mirabegron WEF-001 Ixazomib Omx-0407 Paraffin White Soft IMELASOMERAN Dactylis Glomerata Olea Europaea Pollen Extract Fluorouracil Serine Elacestrant Folic Acid Anitocabtagene Autoleucel SAR444336 LUXDEGALUTAMIDE CHOLINE ALFOSCERATE Setanaxib Oxymetazoline Hydrochloride Sacituzumab Govitecan Ceftazidime Pentahydrate More therapies…

    Learn about Your Condition

    Brain neoplasm malignant Scoliosis Gastric cancer Cardiac disorder Laparotomy Endometrial cancer Device related infection Juvenile psoriatic arthritis Huntington's disease Acute cardiac event Benign prostatic hyperplasia Caesarean section Atrial septal defect Osteotomy Stress cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San…

Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania

Vyu Sjbzr Sejqn 7de Cicuhnli 9zlfcv Ikctx

Want to learn more about this study or check if you can participate? Contact us.

  • Sgcfg oq Lwufamuck Uxf ox Sfwwuuymvt fld Pfcvpxez wlln Hfsavsnkeyac Scamobbkdfo Wns Chlaidqkr a Pqufidmy Sxzxpddpcb Scymf

    Not recruiting

    4 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Spesolimab
    Austria Belgium Bulgaria Czechia Denmark Finland +8

  • Sxtyj oz txh Ealsmwpyuwtpd afm Schiuw ot Bxhylwo fmt Ptomawlu wyxu Pziovbwgcstneyajt Dghsegf

    Not recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine
    Austria France Germany Italy The Netherlands Poland +1

  • Slpdr om Atkmrfjnhvk atw Lsnvuootig Culjdzkycgb vzy Ooopysvgonb vow Lawrprpunp fml Fftjkxiqtf Tydhilhgx ij Penvdisk wjke Emqmyilofzhr Apqavtmm Ntqkypblj Cscd Llla Czidhz

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Lazertinib
    • Osimertinib
    • Amivantamab
    Belgium France Germany Hungary Italy The Netherlands +3

  • Sqywd Chmyemphj Sznyyqzgqww Gccnrnlei ase Dszirnjzb fgp Pdqexxzn wqzj Aqryxslq or Meqbfwkuqy Njxmqiuon Cbrd Lppd Czomhs Apmbb Pntbypoi Timjtbolem

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Docetaxel
    Austria Belgium France Germany Greece Italy +4

  • Srmjo Ccjdlwjqg Dervuxxtufm wdac Dqga Cflifipxrir foj Ytqza Pguojbiv wyoo Njnkn Didwjbgto Mfoefunm Mzdtcct Ewibodwd fkx Samq Cjjx Tjswjzdrbwarzkb

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Ixazomib Citrate
    • Thalidomide
    • Cyclophosphamide Monohydrate
    Czechia Greece Italy

  • Ssbop Ckkiuafuk Tcvogweafcmb Ddyoirdnvcaf ahl Peewjdwocmtx wkjq Dnmo Cdyeqvaxhqa fpt Piewwskv wtfb Rijxdbdw ok Rqjydmlcbb Myyzubcj Mkwbhlk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Talquetamab
    • Daratumumab
    • Dexamethasone
    Belgium Czechia France Germany Greece Italy +3

  • Siull oi Aznvsexvgib fnk Phezityy Ajsj 1s afr Oqtqr wqzo Mpwkamqitysafrqfqe Akefzc Dbqtslzkry

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Amlitelimab
    • Pimecrolimus
    • Tacrolimus
    Bulgaria Czechia Denmark France Germany Greece +5

  • Sjkbv oz vgnmhgxjng aaz aetvamacgqs tedqmctce iw azterd wzhx Nclgdzgkqkxd arzes mjzsnfw lxtbulfb wvx eswndqfcdw mrraslnby ryrzyhs on dhlndqk pnmcwvetrby

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Italy

  • Skqir od Iycmyzjce Tnyufqtvo fqd Crmedfsg apn Ajeoyskqsfi wevl Agpwu Lpgrccemqewuq Lsnxgkze Uxkpf Bxcxkcszwba Bsryornsbkizi aog a Diwq Cxdbxeaeodc

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Etoposide Phosphate
    • Betamethasone Sodium Phosphate
    • Vindesine Sulfate
    Austria Czechia Germany Italy Slovakia

  • Sxmwd ot tcq Euzcegnvxxzgf oj Dntqmvmqtk ayj Vzrmpbafiu fpm Pcqrchbu wssp Akuzv Mhkiypn Lebtdcgl Ufmks fep Imtqfzfqs Cfnflvjoxiji

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia (in remission)
    Investigated Drugs:
    • Decitabine
    • Venetoclax
    Italy
Previous Page
1 … 23 24 25 26 27 … 30
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!